(Q33574876)

English

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy

scientific article

Statements

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy (English)
30 October 2015
1103-10.e1-11

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit